How can we identify parasite genes that underlie antimalarial drug resistance?

Author： Anderson Tim   Nkhoma Standwell   Ecker Andrea   Fidock David  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.1, 2011-01, pp. : 59-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Functional Cloning as a Means to Identify Leishmania Genes Involved in Drug Resistance

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 123-129

Bentham Science Publishers

Access to resources Recommend Favorite

Antimalarial Drug Resistance and Early Drug Discovery

By  

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 270-281

Bentham Science Publishers

Access to resources Recommend Favorite

How can we enable drug discovery informatics for personalized healthcare?

By Scheiber Josef  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 219-224

Informa Healthcare

Access to resources Recommend Favorite

Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?

By Petri W.A.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 210-212

Elsevier

Access to resources Recommend Favorite

Targeting Protein Kinases in the Malaria Parasite: Update of an Antimalarial Drug Target

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-03 ,pp. : 456-472

Bentham Science Publishers

Access to resources Recommend Favorite